407 related articles for article (PubMed ID: 25823617)
1. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
2. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
4. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
6. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
7. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
[TBL] [Abstract][Full Text] [Related]
9. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
10. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
11. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
[TBL] [Abstract][Full Text] [Related]
13. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay.
Rothan HA; Zulqarnain M; Ammar YA; Tan EC; Rahman NA; Yusof R
Trop Biomed; 2014 Jun; 31(2):286-96. PubMed ID: 25134897
[TBL] [Abstract][Full Text] [Related]
14. An Antiviral Peptide from
Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
[TBL] [Abstract][Full Text] [Related]
16. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
17. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
18. Novel dengue virus NS2B/NS3 protease inhibitors.
Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.
Liu H; Wu R; Sun Y; Ye Y; Chen J; Luo X; Shen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(22):6344-52. PubMed ID: 25438757
[TBL] [Abstract][Full Text] [Related]
20. Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.
Tomlinson SM; Watowich SJ
Antiviral Res; 2011 Feb; 89(2):127-35. PubMed ID: 21185332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
